Stocks · Health care · Services-Medical Laboratories

VERACYTE, INC.

VCYT Clue Score73
United States Fiscal year ends December CIK 0001384101 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Karin Eastham
27 Oct 2026
Director
Sold after exercise
14,850
$50.00
$742.57K
Jens Holstein
27 Oct 2026
Director
Sold after exercise
7,500
$50.00
$375.00K
Jens Holstein
24 Sep 2026
Director
Sold after exercise
7,500
$47.00
$352.50K
Marc Stapley
4 Jun 2026
Chief Executive Officer
Sold after exercise
138,051
$50.12
$6.92M
Jonathan Wygant
22 May 2026
VP, Chief Accounting Officer
Sold after exercise
24,000
$45.40
$1.09M
Karin Eastham
5 Dec 2025
Director
Sold after exercise
800
$46.59
$37.27K
Karin Eastham
5 Dec 2025
Director
Sold after exercise
12,808
$45.84
$587.08K
Karin Eastham
5 Dec 2025
Director
Sold after exercise
6,392
$44.52
$284.57K

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 8
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,166,749
History held since 4 Nov 2013